ASTH
Astrana Health
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ASTH
- PE Ratio
The current PE ratio for Astrana Health stock as of Aug 13, 2026 is 45.53. This is calculated based on the TTM EPS of $0.83 and the stock price of $37.79 per share. The PE ratio marks a decrease of 37% from its last 4 quarters average of 72.8.
ASTH PE ratio history
The average historical PE ratio of Astrana Health for the last nine years is 43.28. The current P/E ratio of 45.53 is 5% higher than the historical average. Looking back at the last nine years, ASTH's PE ratio peaked in the Sep 2019 quarter at 160.18, when the price was $17.62 and the EPS was $0.11. The lowest point was in the Mar 2018 quarter, when it reached 17.72 with a price of $15.95 and an EPS of $0.9.
Astrana Health PE ratio by year
Maximum annual increase: 163.81% in 2021
Maximum annual decrease: -60.49% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 53.93 | 55.64% | $24.81 | $0.46 |
| 2024 | 34.65 | 17.62% | $31.53 | $0.91 |
| 2023 | 29.46 | -0.44% | $38.3 | $1.3 |
| 2022 | 29.59 | -36.77% | $29.59 | $1 |
| 2021 | 46.8 | 163.81% | $73.48 | $1.57 |
| 2020 | 17.74 | -60.49% | $18.27 | $1.03 |
| 2019 | 44.9 | -25.35% | $18.41 | $0.41 |
| 2018 | 60.15 | 153.16% | $19.85 | $0.33 |
| 2017 | 23.76 | N/A | $24 | $1.01 |
| 2016 | N/A | N/A | N/A | $0.46 |
| 2015 | N/A | N/A | N/A | -$0.37 |
| 2014 | N/A | N/A | N/A | -$1.37 |
| 2013 | N/A | N/A | N/A | -$2.7 |
Astrana Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 55.92 | 41.39% | $46.41 | $0.83 |
| Mar 2026 | 39.55 | -26.66% | $24.52 | $0.62 |
| Dec 2025 | 53.93 | -61.95% | $24.81 | $0.46 |
| Sep 2025 | 141.75 | 201.98% | $28.35 | $0.2 |
| Jun 2025 | 46.94 | 12% | $24.88 | $0.53 |
| Mar 2025 | 41.91 | 20.95% | $31.01 | $0.74 |
| Dec 2024 | 34.65 | -21.66% | $31.53 | $0.91 |
| Sep 2024 | 44.23 | 57.01% | $57.94 | $1.31 |
| Jun 2024 | 28.17 | -11.44% | $40.56 | $1.44 |
| Mar 2024 | 31.81 | 7.98% | $41.99 | $1.32 |
| Dec 2023 | 29.46 | -10.24% | $38.3 | $1.3 |
| Sep 2023 | 32.82 | 2.82% | $30.85 | $0.94 |
| Jun 2023 | 31.92 | -14.22% | $31.6 | $0.99 |
| Mar 2023 | 37.21 | 25.75% | $36.47 | $0.98 |
| Dec 2022 | 29.59 | -2.12% | $29.59 | $1 |
ASTH Price vs fair value
ASTH average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, ASTH's PE ratio is higher than its 5-year average, but it is lower than its 3-year average.
PE comparison
With a price to earnings (P/E) of 45.53, ASTH ranks higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 24.28, Astrana Health's price to earnings (P/E) is 88% higher.
ASTH PE vs peers
Frequently asked questions
What is Astrana Health's PE ratio?
As of Aug 13, 2026, ASTH stock has a price to earnings ratio of 45.53.
What is the 3-year average PE ratio for Astrana Health (ASTH)?
Over the last 3 years, the average price to earnings ratio for ASTH stock is 48.43.
What is the 5-year average PE ratio for Astrana Health (ASTH)?
Over the last 5 years, the average price to earnings ratio for ASTH stock is 43.44.
What is the highest PE ratio for ASTH?
Over the last nine years, the quarterly PE ratio reached its highest level at 160.18 in the Sep 2019 quarter.
How does the current PE ratio for ASTH compare to its historical average?
The current PE ratio of ASTH is 5% higher than the 9-year historical average.
How is ASTH's PE ratio calculated (Astrana Health PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Aug 13, 2026), Astrana Health's share price is $37.79. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $0.83. Therefore, Astrana Health's PE ratio for today is 45.53. PE RATIO(45.53) = STOCK PRICE($37.79) / TTM EPS($0.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.